Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of Novaferon for locally advanced pancreatic adenocarcinoma
ChiCTR-TRC-10001000Phase 2Suspended
- Sponsor
- Changhai Hospital
- Start
- Sep 2010
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label trial of novaferon in pancreatic adenocarcinoma (PDAC) (3 arms), sponsored by Changhai Hospital. Primary endpoints: Disease control rate and Objective response rate. Started Sep 2010; status: suspended.
02
Drugs
novaferon
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on ChiCTR-TRC-10001000.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-10001000.